Steris (NYSE:STE) Trading 0.6% Higher

Share on StockTwits

Steris PLC (NYSE:STE)’s share price traded up 0.6% during trading on Wednesday . The stock traded as high as $118.99 and last traded at $118.82, 30,038 shares were traded during trading. A decline of 97% from the average session volume of 973,133 shares. The stock had previously closed at $118.11.

Several equities analysts recently commented on the company. Northcoast Research restated a “buy” rating on shares of Steris in a research report on Wednesday, February 12th. Stephens cut their target price on Steris from $177.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $144.75.

The stock has a fifty day moving average of $150.44 and a two-hundred day moving average of $148.55. The stock has a market capitalization of $10.02 billion, a price-to-earnings ratio of 28.18 and a beta of 0.80. The company has a current ratio of 2.34, a quick ratio of 1.78 and a debt-to-equity ratio of 0.37.

Steris (NYSE:STE) last released its quarterly earnings results on Monday, February 10th. The medical equipment provider reported $1.45 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.03. Steris had a return on equity of 16.33% and a net margin of 13.21%. The firm had revenue of $774.30 million during the quarter, compared to analysts’ expectations of $748.45 million. During the same period last year, the firm posted $1.26 EPS. The business’s revenue was up 11.2% on a year-over-year basis. Equities analysts expect that Steris PLC will post 5.63 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, February 25th were paid a $0.37 dividend. The ex-dividend date was Monday, February 24th. This represents a $1.48 annualized dividend and a dividend yield of 1.14%. Steris’s dividend payout ratio (DPR) is currently 30.27%.

In other news, Director Mohsen Sohi sold 3,121 shares of Steris stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $165.65, for a total value of $516,993.65. Following the completion of the sale, the director now directly owns 25,482 shares of the company’s stock, valued at approximately $4,221,093.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.36% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in STE. Lenox Wealth Management Inc. lifted its holdings in shares of Steris by 7.5% in the fourth quarter. Lenox Wealth Management Inc. now owns 970 shares of the medical equipment provider’s stock valued at $148,000 after purchasing an additional 68 shares in the last quarter. Wealthfront Advisers LLC lifted its holdings in shares of Steris by 5.0% in the fourth quarter. Wealthfront Advisers LLC now owns 1,477 shares of the medical equipment provider’s stock valued at $225,000 after purchasing an additional 71 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Steris by 2.3% in the fourth quarter. Signaturefd LLC now owns 4,304 shares of the medical equipment provider’s stock valued at $656,000 after purchasing an additional 98 shares in the last quarter. Fulton Bank N.A. lifted its holdings in shares of Steris by 4.6% in the fourth quarter. Fulton Bank N.A. now owns 2,412 shares of the medical equipment provider’s stock valued at $368,000 after purchasing an additional 107 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Steris by 1.0% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 10,847 shares of the medical equipment provider’s stock valued at $1,653,000 after purchasing an additional 107 shares in the last quarter. 87.85% of the stock is owned by institutional investors.

Steris Company Profile (NYSE:STE)

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Dividend

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insulet  Stock Price Up 5.9%
Insulet Stock Price Up 5.9%
Steris  Trading 0.6% Higher
Steris Trading 0.6% Higher
Neenah  Trading 0.9% Higher
Neenah Trading 0.9% Higher
iCAD  Trading 2.5% Higher
iCAD Trading 2.5% Higher
Pico  Shares Up 5%
Pico Shares Up 5%
BGC Partners  Trading 13.7% Higher
BGC Partners Trading 13.7% Higher


© 2006-2020 Ticker Report